Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT05705102

Time for a Paradigm Shift: STEMI/NSTEMI to OMI/NOMI ?

Conditions: Myocardial Infarction, Myocardial Ischemia

Sex: All
Ages: 18 Years – 90 Years
Enrollment: 2500
Sponsor: Marmara University

Location: Turkey

Summary

The current ST-segment elevation (STEMI)/non-STEMI treatment paradigm misses nearly one fourth of acute coronary occlusions (ACO) that needs immediately reperfusion. Many of these cases can be recognized by subtle changes on ECG, but the current STEMI criteria do not include them. The investigators of this research believe a new occlusive/non-occlusive myocardial infarction (OMI/NOMI) approach will be superior to the established STEMI/non-STEMI paradigm in early detection of ACO, limiting infarct size, reducing re-hospitalizations and most important of all, reducing mortality.

Eligibility Criteria

Inclusion Criteria:Clinical picture compatible with acute coronary syndrome AND recognized as OMI/STEMI (according to the treating provider) or cardiac high-sensitive troponins levels are elevatedExclusion Criteria:Unable to acquire ECG

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05705102). StuddyBuddy aggregates publicly available trial information.